International consensus guidance for management of myasthenia gravis: Executive summary - Wikidata - awgldk - TriplyDB

International consensus guidance for management of myasthenia gravis: Executive summary

International consensus guidance for management of myasthenia gravis: Executive summary

http://www.wikidata.org/entity/Q26746047

about

Thymectomy in Myasthenia Gravis Anti-MuSK-Positive Myasthenic Crisis in a 7-Year-Old Female.Tracheoesophageal Fistula Caused by Tracheostomy in a Patient with Myasthenia Gravis after a Myasthenic Crisis.Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.Severe Preeclampsia in the Setting of Myasthenia Gravis.Myasthenia gravis: recent advances in immunopathology and therapy.Rituximab treatment of myasthenia gravis: A systematic review.Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience.Open source modular ptosis crutch for the treatment of myasthenia gravis.Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy in the same patient - a case report.Myasthenia gravis with antibodies to MuSK: an update.Factors affecting outcome in ocular myasthenia gravis.Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan.Eculizumab: A Review in Generalized Myasthenia Gravis.Fatigue as a symptom or comorbidity of neurological diseases.The Association of British Neurologists' myasthenia gravis guidelines.Probable vancomycin-induced myasthenic crisis: a case report.Randomized trial of thymectomy in myasthenia gravis.Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin.Prompt Response to Prednisone Predicts Benign Course in MuSK-MG.The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.Thymectomy in nonthymomatous myasthenia gravis - systematic review and meta-analysis.Optimal timing of thymectomy in nonthymomatous myasthenia gravis patients in China: A prospective study Rituximab Treatment in : Report of two paediatric cases New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis Recent advances in understanding and managing myasthenia gravis

P2860

Q33557437-6CBFDFDB-639F-4EBC-AEDC-F8B9685753F7 Q33678805-EC6D9568-379C-450D-8DAB-E976E606A77A Q33705216-FBE7367C-3C0F-43D0-991D-933994699EDC Q33711385-B4CD0AF3-7000-4B03-8439-24479CF13BB1 Q37661148-084C4648-9089-4681-8FB5-22EB316AAA0D Q38969032-2EB05772-09E0-4AEA-83F3-96CB7C92014F Q39121466-7532DB0C-898A-4431-9AD9-DB21E74BDB58 Q41657907-23146007-DBEF-4342-9EF2-E97D75544DEF Q47186616-5F65D89C-8047-4E5C-9E96-F525772F81B2 Q47599505-11540FA1-CE10-4B22-B5A9-0E881AA0CC46 Q47674286-07DFDD4A-7E24-4A06-ACBE-22CF4275FE79 Q47690888-5E7FE8F5-A345-4FD9-8993-FDBF58BE53F3 Q49629485-6825EAAB-ED48-4559-8150-FF29F8A2579C Q50050547-83181E08-9208-4499-B49E-C8F468B72278 Q50063088-39C3AF08-C31E-44DA-BCFE-A78707F44A65 Q50091590-1FF594B0-EBAE-4903-9AF8-5DE3E22F1258 Q50120500-AEC879A7-7A2C-4BDE-923D-6C89427F5F69 Q53533743-AC8194C5-D2D2-4067-B2F7-CEB72355A74D Q54253821-02DB7AAD-2C1D-4013-99F3-9D1626774494 Q54990030-2AE99FF5-6CC2-43C5-8D8B-9221477CD0C8 Q55228908-C6681122-EAB1-447D-A1A4-03D1B95ABC15 Q55267717-17220705-0ED7-42FD-8DF1-FE61A74B9006 Q55490494-0420E3C0-5E09-46CE-B154-DB6F41DCBA9A Q58704263-FBCAAD4B-99A8-4CB4-AF14-9373592B1605 Q58757308-70182ED8-D0D4-44B5-9F12-6E3726F0C5F0 Q58803309-6336F329-FE03-436B-9F07-5A41EFEAC27D Q59138256-186BDEED-1B1C-4A14-892C-B314600D54DC

P2860

International consensus guidance for management of myasthenia gravis: Executive summary

http://www.wikidata.org/entity/Q26746047

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

International consensus guidance for management of myasthenia gravis: Executive summary

@ast

International consensus guidance for management of myasthenia gravis: Executive summary

@en

International consensus guidance for management of myasthenia gravis: Executive summary

@nl

type

label

International consensus guidance for management of myasthenia gravis: Executive summary

@ast

International consensus guidance for management of myasthenia gravis: Executive summary

@en

International consensus guidance for management of myasthenia gravis: Executive summary

@nl

prefLabel

International consensus guidance for management of myasthenia gravis: Executive summary

@ast

International consensus guidance for management of myasthenia gravis: Executive summary

@en

International consensus guidance for management of myasthenia gravis: Executive summary

@nl

P1433

Q26746047-B9A8E46A-244D-462E-A51B-1BD9CC92AF5F

P1476

Q26746047-B8875BD6-FF76-4117-B14D-83D0A0F01683

P2093

Q26746047-00F9C53F-E43A-4E20-B987-23A21C53A1B4

Q26746047-22AD621A-BBF2-4919-99B5-AB1B7B2C9C9D

Q26746047-23537602-3038-48C9-9F20-35D8186E45D9

Q26746047-36C2F816-3EF1-448F-871C-6D4AB5BB453C

Q26746047-3D5F82DA-2004-4FA3-AD69-E3D9765FBBF2

Q26746047-3D77B583-4A8F-496C-AE45-C6ECF82F65BC

Q26746047-417EFA70-F6F0-441E-B673-5BB894ED10B6

Q26746047-5EFBA279-4F10-4930-B41D-DD62099311E0

Q26746047-609AD533-DEB3-4D28-955F-5F8FD617709E

Q26746047-94A0CE7D-BF53-449B-BDB4-506E20ABF4C8

P275

Q26746047-8BB22002-4318-40D1-976B-B33A93A2A300

P2860

Q26746047-0C26BE8C-9FD8-4BB2-8160-F810A491B882

Q26746047-3224254C-F3F3-4654-84D4-C9099E3493A2

Q26746047-48A79B1C-977B-44B2-8513-A9A25EC4BCBE

Q26746047-A450A25A-3914-4EBE-B23C-518120C283FE

Q26746047-EBA4A6BA-BB62-4B13-B40C-7B6904061F84

Q26746047-FC01063B-D820-445A-A88E-78AF15FD9E8C

P304

Q26746047-2503D661-1E2D-4ADF-A7E2-8E254CE47863

P31

Q26746047-5EFB1128-0D11-4001-A8CE-A546E38E5AB9

Q26746047-CD0BE4DD-38CA-41D1-8B86-7A2F39F97594

P3181

Q26746047-B763F6D4-29AE-4A40-9E84-2452446F67C7

P356

Q26746047-69C63D5E-B71F-44EA-AF25-B0584EBA77CD

P407

Q26746047-F13A6023-63FB-4518-96AC-83C460BEB8A6

P433

Q26746047-8AB3C7A8-0861-4199-9A35-FEFFB81426C5

P478

Q26746047-7BEA43D8-5AE2-4993-8593-08E811A99D92

P50

Q26746047-66E05B31-A4B0-4643-B7C6-F11E0A63FDE8

Q26746047-70F3F434-5C73-475A-839D-53384A2A8D30

Q26746047-A537061C-8B97-4B19-88A8-AF0AF350F57D

P5008

Q26746047-D3677476-9C86-4F5A-AF3C-3004EE3AFEFB

P577

Q26746047-7F27B21D-04E3-431E-9DBC-7CB4A8C31C36

P698

Q26746047-276358F0-5E1C-444D-B25C-8B206D68EDF3

P921

Q26746047-317F4C29-2A80-4DD1-B836-80D3392F64D6

P932

Q26746047-FAE6C8AE-3C30-424A-BE42-891C80F7CCA1

P3181

P356

WNL.0000000000002790

P1433

P1476

International consensus guidance for management of myasthenia gravis: Executive summary

@en

P2093

Amelia Evoli

http://www.w3.org/2001/XMLSchema#string

Arthur Melms

http://www.w3.org/2001/XMLSchema#string

David P Richman

http://www.w3.org/2001/XMLSchema#string

Donald B Sanders

http://www.w3.org/2001/XMLSchema#string

Gil I Wolfe

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Murai

http://www.w3.org/2001/XMLSchema#string

Isabel Illa

http://www.w3.org/2001/XMLSchema#string

Jan Verschuuren

http://www.w3.org/2001/XMLSchema#string

Janice M Massey

http://www.w3.org/2001/XMLSchema#string

Michael Nicolle

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Guidelines for treatment of autoimmune neuromuscular transmission disorders.

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

Lifetime course of myasthenia gravis.

Myasthenia gravis: Association of British Neurologists' management guidelines.

The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature.

Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group.

P304

419-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4723828

http://www.w3.org/2001/XMLSchema#string

P356

10.1212/WNL.0000000000002790

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Michael Benatar

Jacqueline Palace

Nils Erik Gilhus

P5008

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27358333

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

P932

4977114

http://www.w3.org/2001/XMLSchema#string